Rong Rui, Li Tingting, Zhang Yuyun, Gu Ying, Xia Ningshao, Li Shaowei
National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Sciences, Xiamen University, Xiamen 361102, Fujian, China.
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, Fujian, China.
Sheng Wu Gong Cheng Xue Bao. 2019 Apr 25;35(4):577-588. doi: 10.13345/j.cjb.180301.
Baculovirus expression vector system (BEVS) has been successfully applied to the over-expression of various proteins, thus providing sufficient materials for vaccine research. Compared to other systems, BEVS has many advantages: baculovirus solely being parasitic in invertebrates, the resultant products conferring high safety to mammalian, high expression level of recombinant proteins, preferable folding for eukaryotic protein, proper post-translational modification required for biological function, suitable for multiple genes co-expression and large-scale production with serum-free culture media. To better understand the advantages and prospective of BEVS for the vaccine research, this article will review the development of BEVS and its application on vaccine research.
杆状病毒表达载体系统(BEVS)已成功应用于多种蛋白质的过表达,从而为疫苗研究提供了充足的材料。与其他系统相比,BEVS具有许多优势:杆状病毒仅寄生于无脊椎动物,所产生的产品对哺乳动物具有高度安全性,重组蛋白表达水平高,真核蛋白折叠良好,具有生物学功能所需的适当翻译后修饰,适用于多个基因的共表达以及使用无血清培养基进行大规模生产。为了更好地了解BEVS在疫苗研究中的优势和前景,本文将综述BEVS的发展及其在疫苗研究中的应用。